Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Eiger Biopharmaceuticals
Eiger Biopharmaceuticals
(EIGR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zokinvy
Lonafarnib
2022-07-18
2023-2024
Progeria
,
Laminopathies
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lonafarnib
gliosarcoma
,
colorectal neoplasms
,
glioma
,
astrocytoma
,
central nervous system neoplasms
,
neoplasms
,
sarcoma
,
supratentorial neoplasms
,
brain neoplasms
,
ependymoma
,
oligodendroglioma
,
subependymal glioma
,
male breast neoplasms
,
nervous system neoplasms
,
non-hodgkin lymphoma
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
hodgkin disease
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
large-cell lymphoma anaplastic
,
immunoblastic lymphadenopathy
,
burkitt lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
large-cell lymphoma immunoblastic
,
breast neoplasms
,
progeria
,
glioblastoma
,
chronic hepatitis
,
head and neck neoplasms
,
prostatic neoplasms
,
ovarian neoplasms
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
liver diseases
,
hepatitis
,
hepatitis a
,
squamous cell carcinoma
,
squamous cell neoplasms
,
stomach neoplasms
,
fibrosis
,
ovarian epithelial carcinoma
,
carcinoma
,
squamous cell carcinoma of head and neck
,
liver neoplasms
,
urinary bladder neoplasms
,
urethral neoplasms
,
transitional cell carcinoma
,
hepatitis d
,
chronic hepatitis d
,
syndrome
,
lung neoplasms
,
leukemia
,
myelodysplastic syndromes
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia juvenile
,
preleukemia
,
non-small-cell lung carcinoma
,
neoplasm metastasis
,
hepatitis b
,
laminopathies
Alfacalcidol
asthma
,
non-small-cell lung carcinoma
,
lung injury
,
lung neoplasms
,
smoking
,
family relations
Avexitide
type 2 diabetes mellitus
,
diabetes mellitus
,
hyperglycemia
Bevifimod
primary ovarian insufficiency
,
female infertility
,
ovulation induction
,
infertility
,
asthma
,
fertilization in vitro
,
dysmenorrhea
,
contraception
,
proteinuria
,
cardiovascular diseases
,
myocardial infarction
,
ischemia
,
acute coronary syndrome
,
myocardial ischemia
,
angina pectoris
,
psoriasis
,
ovarian hyperstimulation syndrome
,
pregnancy
,
congenital abnormalities
,
hemorrhage
,
hypercholesterolemia
,
dyslipidemias
Clemizole
hepatitis c
,
hepatitis
,
hepatitis a
Nepidermin
colorectal neoplasms
,
neoplasm metastasis
Ubenimex
hypertension
,
pulmonary arterial hypertension
,
familial primary pulmonary hypertension
,
lymphedema
Fendrix
hepatitis b virus
,
chronic disease
,
hepatitis b
,
hepatitis
,
hepatitis a
,
chronic hepatitis b
,
chronic hepatitis
,
infections
,
communicable diseases
,
virus diseases
,
herpesviridae infections
,
hiv infections
,
viremia
,
non-hodgkin lymphoma
,
lymphoma
,
liver diseases
,
hepatitis c
,
melanoma
,
recurrence
Ebp921
hepatitis d
,
hepatitis
,
hepatitis a
Mevalotin
hypercholesterolemia
,
hypertension
,
cardiovascular diseases
,
stroke
,
myocardial infarction
,
diabetes mellitus
,
dyslipidemias
Exendin9
type 2 diabetes mellitus
,
diabetes mellitus
,
healthy volunteers/patients
,
hyperglycemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use